Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLC.
Yongyuan ChenZheyu ShaoZhixing HaoZhongwei XinXiaoke ChenLijian HuangDi ChenMingjie LinQinyuan LiuXia XuJinfan LiDang WuJun YanYing ChaiPin WuPublished in: Journal for immunotherapy of cancer (2024)
NCT03732664.